The Planning Strategy: Syngeneic, PDX, Humanized, Xenografts, Orthotopics, and More

Do you wonder which oncology mouse models to test and in what sequence when planning your in vivo oncology approaches? What questions does each type answer? How do you get the answers you need without missing an important piece of the puzzle? Does the FDA require testing in PDX?

This webinar will discuss the pros, cons, and applications of the major mouse models currently used in cancer research and how to use them synergistically to meet your goals.

Presenter

  • Eddie Wood, PhD, Research Director, Charles River